Lexaria Bioscience(LEXX.US)

Last Updated 19:00:00 ET
longbridge loading

Lexaria Receives Independent Review Board Approval to Begin Human Pilot Study #7 | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
VHT
+0.12%
US
XBI
+3.63%
StockTitan·
US
LEXX
+3.86%
US
VHT
+0.12%
US
XBI
+3.63%

Lexaria Updates Progress on Human Study #7 | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
BBH
+0.68%
US
LABU
+10.78%
StockTitan·
US
LEXX
+3.86%
US
BBH
+0.68%
US
LABU
+10.78%

Lexaria Bioscience Launches Ongoing Investor Video Series to Expand Shareholder Communications | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
LABU
+10.78%
US
XLV
-0.22%
StockTitan·
US
LEXX
+3.86%
US
LABU
+10.78%
US
XLV
-0.22%

Material Transfer Agreement Between Pharmaceutical Company and Lexaria is Extended | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
LABU
+10.78%
US
IBB
+1.90%
StockTitan·
US
LEXX
+3.86%
US
LABU
+10.78%
US
IBB
+1.90%

Lexaria Launches New Study to Examine Next-Generation GLP-1 Drugs | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
IBB
+1.90%
US
PBE
+1.37%
StockTitan·
US
LEXX
+3.86%
US
IBB
+1.90%
US
PBE
+1.37%

Lexaria Expects Oral GLP-1 Pills to Generate Billions in New Industry Sales | LEXX Stock News

StockTitan·
US
LEXX
+3.86%
US
SBIO
+3.97%
US
LABU
+10.78%
StockTitan·
US
LEXX
+3.86%
US
SBIO
+3.97%
US
LABU
+10.78%
© 2026 Longbridge｜Disclaimer